Celltrion Sees Sales Dip In Q3

As Company Sees Pro-Biosimilar Policies Offering A Boost In US

 
• By Akriti Seth
  
Sales decline glasses pen chart graph table
Celltrion delivers a weak quarter with double-digit drop in revenues • Source: Alamy

More from Earnings

More from Business